Table 1.
Mold | Mold Component |
Species | Disease/ Model |
Measured Surrogate Marker | Outcome | Source |
---|---|---|---|---|---|---|
Increased Asthma severity | ||||||
A. fumigatus | Spores | Human | Asthma | Total serum IgE ↑ Blood eosinophils (cells/µL) ↑ FEV1/FVC (%) ↓ |
Asthma severity increased | [50] |
Penicillium spp. | Spores | Human | Asthma | FEV1/FVC (%) ↓ | Asthma severity increased | [50] |
n.a. | GTX Patulin |
Mouse | Allergic asthma/ OVA-model |
Airway inflammation ↑ OVA-IgE ↑ BAL eosinophils ↑ |
Asthma severity increased | [54] |
Involved in autoimmune response | ||||||
Mold water damage | n.a. | Human | n.a. | IgG neuronal antibodies against microtubule-associated protein-2, myelin basic protein, tau, glial fibrillary acidic protein, tubulin, and S-100B | No clincial outcome | [57] |
n.a. | GTX | Mouse | EAE | Neuroinflammation ↑ Demyelination ↑ |
Aggravation of autoimmune encephalomyelitis | [58] |
A. fumigatus |
A. fumigatus antigens (I and VIII) |
Human | RA | IgG ↑ IgA ↑ |
Stronger sensitization than control subjects | [62] |
n.a. | OTA DON |
Mouse | RA DBA1 model |
IgG1 ↑ IG2a ↑ Pro-inflammatory cytokines ↑ |
Clinical severity score ↑ | [63] |
Trigger of IBD | ||||||
S. chartarum | Trichothecene group | Human | CU/CSF HLA-DR/DQ susceptible |
Mycotoxin test in urine-positive |
Pancreatitis improved after withdrawn | [65] |
n.a. | DON | Rat | CU DSS model |
Morphological damage in colon ↑ Colonic inflammation ↑ |
Exacerbation of onset and symptoms of DSS-induced colitis | [67] |
Worsening of HIV condition | ||||||
Aspergillus spp. | AFB1 | Human | HIV-positive adults | Plasma aflatoxin B1 ↑ HIV-1 RNA ↑ |
Higher viral loads in HIV-positive humans with higher AF-ALB | [69,70] |